1-substituted-7-( -D-glycopyranosyloxy)(aza)indole compound and pharmaceutical containing the same

The present invention provides a compound having an SGLT1 and/or SGLT2 inhibitory activity which is usable as an agent for the prevention or treatment of diabetes, postprandial hyperglycemia, impaired glucose tolerance, diabetic complications, obesity or the like. It is a 1-substituted-7-( -D-glycop...

Full description

Saved in:
Bibliographic Details
Main Authors FUSHIMI NOBUHIKO, OHNO KOHSUKE, YONEKUBO SHIGERU
Format Patent
LanguageEnglish
Published 06.07.2010
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:The present invention provides a compound having an SGLT1 and/or SGLT2 inhibitory activity which is usable as an agent for the prevention or treatment of diabetes, postprandial hyperglycemia, impaired glucose tolerance, diabetic complications, obesity or the like. It is a 1-substituted-7-( -D-glycopyranosyloxy)(aza)-indole compound represented by the general formula (I), a prodrug thereof, or a pharmaceutically acceptable salt thereof, or a hydrate or solvate thereof: wherein R1 represents a halogen atom or the like; n represents j an integer number from 0 to 3; R2 represents a hydrogen atom or the like; X represents a carbon atom which a hydrogen atom or the like binds to, or a nitrogen atom; Q represents an alkylene group or an alkenylene group each of which may have an oxygen atom or a sulfur atom in the chain; and A represents an aryl or heteroaryl group which may have a substituent.
Bibliography:Application Number: US20060816056